Lusvertikimab [CAS 2375835-91-7]
Partner: MedChemexpress LLC
| CAS No: | 2375835-91-7 |
| Applications: | Cancer-Kinase/protease |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Lusvertikimab] |
| Purity: | 99.41 |
| Description: | Lusvertikimab (OSE-127) is a humanized IL7R monoclonal antibody. Lusvertikimab is not internalized by target cells and prevents IL7R heterodimerization and subsequent downstream signaling. Lusvertikimab has anti-leukemic efficacy and has the potential for B cell precursor acute lymphoblastic leukemia (BCP-ALL) research[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
